ELDERLY PATIENTS >65YEARS OF AGE WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME GAIN LIFE TIME FROM TREATMENT WITH TUMOR TREATING FIELDS AND TEMOZOLOMIDE

被引：0
|
作者：
Guzauskas, G. F. [1 ]
Wang, B. C. M. [1 ]
Kinzel, A. [2 ]
Proescholdt, C. [3 ]
机构：
[1] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
[2] Novocure, Munich, Germany
[3] Novocure, Root, Switzerland
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P01.110
引用
收藏
页码：256 / 257
页数：2
相关论文
共 50 条
  • [1] ELDERLY PATIENTS >65YEARS OF AGE WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME GAIN LIFE TIME FROM TREATMENT WITH TUMOR TREATING FIELDS AND TEMOZOLOMIDE
    Guzauskas, Gregory
    Wang, Bruce C. M.
    Proescholdt, Christina
    NEURO-ONCOLOGY, 2018, 20 : 116 - 116
  • [2] COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE
    Guzauskas, Gregory
    Wang, Bruce C. M.
    Pollom, Erqi
    Stieber, Volker W.
    Garrison, Lou
    NEURO-ONCOLOGY, 2018, 20 : 116 - 117
  • [3] COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE
    Guzauskas, G. F.
    Wang, B. C. M.
    Pollom, E. L.
    Stieber, V. W.
    Kinzel, A.
    Proescholdt, C.
    Garrison, L.
    NEURO-ONCOLOGY, 2018, 20 : 254 - 254
  • [4] Eighteen years' experience with tumor treating fields in the treatment of newly diagnosed glioblastoma
    Vymazal, Josef
    Kazda, Tomas
    Novak, Tomas
    Slanina, Petr
    Sroubek, Jan
    Klener, Jan
    Hrbac, Tomas
    Syrucek, Martin
    Rulseh, Aaron M. M.
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [5] TUMOR TREATING FIELDS COMBINE WITH TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA: A RETROSPECTIVE ANALYSIS OF CHINESE PATIENTS
    Qin, Zhiyong
    Chen, Lingchao
    Chen, Junrui
    Yao, Yu
    Wu, Jinsong
    Zhuang, Dongxiao
    Nie, Jigntao
    NEURO-ONCOLOGY, 2022, 24 : 82 - 82
  • [6] TUMOR TREATING FIELDS COMBINED WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA: FINAL RESULTS FROM A PILOT STUDY
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Blumenthal, Deborah
    Ben Harush, Camit
    Ram, Zvi
    NEURO-ONCOLOGY, 2019, 21 : 23 - 24
  • [7] TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nicholas, Garth A.
    Hirte, Holger
    Easaw, Jacob
    Muanza, Thierry
    Roberge, David
    Mathieu, David
    Pitz, Marshall
    NEURO-ONCOLOGY, 2017, 19 : 138 - 138
  • [8] Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center
    Chen, Chunjui
    Xu, Hao
    Song, Kun
    Zhang, Yi
    Zhang, Junyan
    Wang, Yang
    Sheng, Xiaofang
    Chen, Lingchao
    Qin, Zhiyong
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [9] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, Lazaros
    Schaefer, Niklas
    Kebir, Sied
    Weller, Johannes
    Tzaridis, Theophilos-Dimitrios
    Scheffler, Bjoern
    Pierscianek, Daniela
    Kleinschnitz, Christoph
    Stuschke, Martin
    Sure, Ulrich
    Herrlinger, Ulrich
    Glas, Martin
    NEURO-ONCOLOGY, 2018, 20 : 119 - 120
  • [10] RETROSPECTIVE ANALYSIS OF USING RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR CHINESE PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Wang, Yang
    Wu, Jingsong
    Qin, Zhiyong
    Wang, Enmin
    Yao, Yu
    Zhuang, Dongxiao
    Liang, Lipin
    Ni, Chunxia
    Lu, Peijiang
    Chen, Shu
    Li, Chao
    NEURO-ONCOLOGY, 2021, 23 : 72 - 72
12345